USD 0.02
(3.88%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -1238.00 USD | 0.08% |
2022 | -1239.00 USD | 0.0% |
2021 | -1239.00 USD | 0.0% |
2020 | -1239.00 USD | -116.12% |
2019 | 7688.00 USD | 135.44% |
2018 | -21.69 Thousand USD | -113.16% |
2017 | 164.82 Thousand USD | 0.0% |
2015 | 46.46 Thousand USD | 135.45% |
2014 | -131.09 Thousand USD | -1023168.52% |
2013 | 12.81 USD | 0.0% |
2009 | 15.37 Thousand USD | -10.42% |
2008 | 17.16 Thousand USD | -67.85% |
2007 | 53.39 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | - USD | 100.0% |
2024 Q1 | -310.00 USD | -0.65% |
2023 Q2 | - USD | 100.0% |
2023 Q1 | -310.00 USD | -0.32% |
2023 Q4 | -308.00 USD | 0.65% |
2023 FY | -1238.00 USD | 0.08% |
2023 Q3 | -310.00 USD | 0.0% |
2022 FY | -1239.00 USD | 0.0% |
2022 Q2 | -310.00 USD | 0.0% |
2022 Q3 | -310.00 USD | 0.0% |
2022 Q4 | -309.00 USD | 0.32% |
2022 Q1 | -310.00 USD | 0.32% |
2021 Q3 | -310.00 USD | -0.32% |
2021 Q4 | -311.00 USD | -0.32% |
2021 Q1 | -309.00 USD | 0.0% |
2021 FY | -1239.00 USD | 0.0% |
2021 Q2 | -309.00 USD | 0.0% |
2020 FY | -1239.00 USD | -116.12% |
2019 FY | 7688.00 USD | 135.44% |
2018 FY | -21.69 Thousand USD | -113.16% |
2017 FY | 164.82 Thousand USD | 0.0% |
2015 FY | 46.46 Thousand USD | 135.45% |
2014 Q2 | -6.24 USD | -779.0% |
2014 FY | -131.09 Thousand USD | -1023168.52% |
2014 Q3 | -0.42 USD | 93.24% |
2014 Q1 | 0.92 USD | -45.91% |
2014 Q4 | -0.44 USD | -3.79% |
2013 Q3 | 2.80 USD | -54.54% |
2013 FY | 12.81 USD | 0.0% |
2013 Q4 | 1.70 USD | -39.36% |
2013 Q2 | 6.16 USD | 186.83% |
2013 Q1 | 2.15 USD | 0.0% |
2010 Q3 | 1463.00 USD | 7.42% |
2010 Q1 | 2004.00 USD | -29.04% |
2010 Q2 | 1362.00 USD | -32.04% |
2009 FY | 15.37 Thousand USD | -10.42% |
2009 Q4 | 2824.00 USD | -23.47% |
2009 Q1 | 4499.00 USD | 0.0% |
2009 Q3 | 3690.00 USD | -15.48% |
2009 Q2 | 4366.00 USD | -2.96% |
2008 FY | 17.16 Thousand USD | -67.85% |
2007 Q1 | 9098.00 USD | 0.0% |
2007 Q2 | 20.33 Thousand USD | 123.51% |
2007 FY | 53.39 Thousand USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
China Medicine Corporation | 18.98 Million USD | 100.007% |
DH Enchantment Inc. | -406.00 USD | -204.926% |
Exlites Holdings International, Inc. | 18.74 Thousand USD | 106.606% |
Itonis, Inc. | 1801.00 USD | 168.74% |
MediPal Holdings Corporation | 1.53 Billion USD | 100.0% |
PD-Rx Pharmaceuticals, Inc. | 6.71 Million USD | 100.018% |
Pharmagen, Inc. | 3045.21 USD | 140.654% |
Suzuken Co., Ltd. | 1.22 Billion USD | 100.0% |